Martinetti A - Search Results

1

Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens.

Martinetti A, Miceli R, Sottotetti E, Di Bartolomeo M, de Braud F, Gevorgyan A, Dotti KF, Bajetta E, Campiglio M, Bianchi F, Bregni G, Pietrantonio F. Martinetti A, et al. Cancers (Basel). 2014 Aug 29;6(3):1753-68. doi: 10.3390/cancers6031753. Cancers (Basel). 2014. PMID: 25256831 Free PMC article.

2

A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma.

Bajetta E, Procopio G, Ferrari L, Martinetti A, Zilembo N, Catena L, Alú M, Della TS, Alberti D, Buzzoni R. Bajetta E, et al. Among authors: martinetti a. Cancer. 2002 Jan 15;94(2):299-304. doi: 10.1002/cncr.10239. Cancer. 2002. PMID: 11900215 Free article. Clinical Trial.

3

Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?

Ferrari L, Bajetta E, Martinetti A, Celio L, Longarini R, La Torre I, Buzzoni R, Gattinoni L, Seregni E, Bombardieri E. Ferrari L, et al. Among authors: martinetti a. Int J Oncol. 2003 May;22(5):1081-9. Int J Oncol. 2003. PMID: 12684675

4

Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate.

Martinetti A, Zilembo N, Ferrari L, Massimini G, Polli A, La Torre I, Giovanazzi R, Pozzi P, Bidoli P, De Candis D, Seregni E, Bombardieri E, Bajetta E. Martinetti A, et al. Anticancer Res. 2003 Jul-Aug;23(4):3485-91. Anticancer Res. 2003. PMID: 12926095 Clinical Trial.

5

The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients.

Zilembo N, Bajetta E, Bichisao E, Martinetti A, La Torre I, Bidoli P, Longarini R, Portale T, Seregni E, Bombardieri E. Zilembo N, et al. Among authors: martinetti a. Biomed Pharmacother. 2004 May;58(4):255-9. doi: 10.1016/j.biopha.2003.12.009. Biomed Pharmacother. 2004. PMID: 15183852 Clinical Trial.

6

Treatment options in hormone-refractory metastatic prostate carcinoma.

Fusi A, Procopio G, Della Torre S, Ricotta R, Bianchini G, Salvioni R, Ferrari L, Martinetti A, Savelli G, Villa S, Bajetta E. Fusi A, et al. Among authors: martinetti a. Tumori. 2004 Nov-Dec;90(6):535-46. doi: 10.1177/030089160409000601. Tumori. 2004. PMID: 15762353 Review.

7

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

Bajetta E, Catena L, Procopio G, De Dosso S, Bichisao E, Ferrari L, Martinetti A, Platania M, Verzoni E, Formisano B, Bajetta R. Bajetta E, et al. Among authors: martinetti a. Cancer Chemother Pharmacol. 2007 Apr;59(5):637-42. doi: 10.1007/s00280-006-0306-6. Epub 2006 Aug 26. Cancer Chemother Pharmacol. 2007. PMID: 16937105

8

Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study.

Bajetta E, Procopio G, Catena L, Martinetti A, De Dosso S, Ricci S, Lecchi AS, Boscani PF, Iacobelli S, Carteni G, De Braud F, Loli P, Tartaglia A, Bajetta R, Ferrari L. Bajetta E, et al. Among authors: martinetti a. Cancer. 2006 Nov 15;107(10):2474-81. doi: 10.1002/cncr.22272. Cancer. 2006. PMID: 17054107 Free article. Clinical Trial.

9

Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma.

Procopio G, Verzoni E, Gevorgyan A, Mancin M, Pusceddu S, Catena L, Platania M, Guadalupi V, Martinetti A, Bajetta E. Procopio G, et al. Among authors: martinetti a. Oncology. 2007;73(3-4):204-9. doi: 10.1159/000127387. Epub 2008 Apr 16. Oncology. 2007. PMID: 18418013

10

Role of the antiangiogenic agent bevacizumab in the treatment of elderly patients with metastatic colorectal cancer.

Di Bartolomeo M, Pietrantonio F, Martinetti A, Buzzoni R, Gevorgyan A, Bajetta E. Di Bartolomeo M, et al. Among authors: martinetti a. Drugs Aging. 2011 Feb 1;28(2):83-91. doi: 10.2165/11584710-000000000-00000. Drugs Aging. 2011. PMID: 21155618 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters